Mesh.i
Exploration
Accueil
Racine
Exploration
Accueil
Racine

Serveur d'exploration Tocilizumab - Exploration (Accueil)

Index « Mesh.i » - entrée « Sulfasalazine »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Substrate Specificity < Sulfasalazine < Sulfonamides  Facettes :

List of bibliographic references indexed by Sulfasalazine

Number of relevant bibliographic references: 10.
Ident.Authors (with country if any)Title
000831 (2019) Laura Bazzichi [Italie] ; Francesca Nacci [Italie] ; Luigi Sinigaglia [Italie] ; Laura Bianchino [Italie] ; Roberto Caporali [Italie]Subcutaneous tocilizumab alone or with a csDMARD in rheumatoid arthritis patients: subanalysis of Italian data from a multicenter phase IIIb/IV trial.
001690 (2017) Tsai-Ling Liao [Taïwan] ; Yi-Ming Chen [Taïwan] ; Hung-Jen Liu [Taïwan] ; Der-Yuan Chen [Taïwan]Risk and severity of herpes zoster in patients with rheumatoid arthritis receiving different immunosuppressive medications: a case-control study in Asia.
001931 (2017) Qingping Yao [États-Unis] ; Bo Shen [États-Unis]A Systematic Analysis of Treatment and Outcomes of NOD2-Associated Autoinflammatory Disease.
001C39 (2016) Maria Gerosa [Italie] ; Tommaso Schioppo [Italie] ; Pier Luigi Meroni [Italie]Challenges and treatment options for rheumatoid arthritis during pregnancy.
001E51 (2015) O. Shovman [Israël] ; Y. Shoenfeld ; P. LangevitzTocilizumab-induced neutropenia in rheumatoid arthritis patients with previous history of neutropenia: case series and review of literature.
002661 (2013) Matthew L. Stoll [États-Unis] ; Randy Q. CronTreatment of juvenile idiopathic arthritis in the biologic age.
002877 (2013) Syed Farhan Bari [Royaume-Uni] ; Afsha Khan [Royaume-Uni] ; Tom Lawson [Royaume-Uni]C reactive protein may not be reliable as a marker of severe bacterial infection in patients receiving tocilizumab
003487 (2012) John M. Davis [États-Unis] ; Eric L. MattesonMy treatment approach to rheumatoid arthritis.
003504 (2012) Anne V. Miller [États-Unis] ; Sriya K M. RanatungaImmunotherapies in rheumatologic disorders.
004220 (2006) H U Scherer [Allemagne] ; G-R Burmester[Biologicals in the treatment of rheumatic diseases].

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i -k "Sulfasalazine" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i  \
                -Sk "Sulfasalazine" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Sulfasalazine
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021